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Lipid droplets (LDs), initially considered “inert” lipid deposits, have gained during the last decade the classiﬁcation of cytosolic
organelles due to their deﬁned composition and the multiplicity of speciﬁc cellular functions in which they are involved. The
classiﬁcation of LD as organelles brings along the need for their regulated turnover and recent ﬁndings support the direct
contribution of autophagy to this turnover through a process now described as lipophagy. This paper focuses on the characteristics
ofthisnewtypeofselectiveautophagyandthecellularconsequencesofthemobilizationofintracellularlipidsthroughthisprocess.
Lipophagy impacts the cellular energetic balance directly, through lipid breakdown and, indirectly, by regulating food intake.
Defective lipophagy has been already linked to important metabolic disorders such as fatty liver, obesity and atherosclerosis, and
the age-dependent decrease in autophagy could underline the basis for the metabolic syndrome of aging.
1.Introduction
Autophagy, or the process of degradation of intracellular
components in lysosomes, has been traditionally linked to
cellular energy balance and to the cellular nutritional status
[1, 2]. In fact, although during the recent revival of the
autophagic process, most of the emphasis has been placed
on its role in other cellular functions such as cellular quality
control, remodeling, or cell defense, the ﬁrst descriptions
of the autophagic process in the early 1960s already stated
that conditions such as starvation lead to its activation [3–
5]. These early studies proposed that autophagic activation
during starvation was necessary to maintain the cellular
energetic balance. Later studies in yeast, in fact conﬁrmed
that activation of autophagy was essential to preserve cellular
viability during nutritional starvation (nitrogen depletion
in yeast), and that mutants defective in autophagy were
lethal [6, 7]. In most of these studies emphasis was placed
on the ability of autophagy to supply through degradation
of protein products the amino acids required to maintain
protein synthesis under the extreme nutritional conditions.
However, the contribution of autophagy to the cellular
energetic balance may not be solely dependent on this
capacity to provide free amino acids, which in fact, are a
relatively ineﬃcient source of energy when oxidized to urea
and carbon dioxide. Recent studies support that autophagy
can also provide energetically more eﬃcient essential com-
ponents, such as free fatty acids (FFAs) and sugars. In this
paper, we focus on the contribution of autophagy to lipid
catabolism and the consequences of this novel autophagic
function in the cellular energetic balance as well as in speciﬁc
lipid-mediated regulatory functions. Lastly, we also discuss
the possible implications of alterations in the autophagic
breakdown of lipids in human health and disease, with
emphasis on common metabolic disorders.
2. Mobilization of LipidDroplets by Autophagy
2.1.TheU pgr adingofLipidDropletstotheOrganelleCategory .
Cells store fat in the form of lipid droplets (LDs)—intra-
cellular deposits of lipid esters surrounded by a monolayer2 International Journal of Cell Biology
Atg12
Atg7
Atg5
LC3-II
Autophagosome Droplet Lipid
PLIN2
PLIN3
Lipase
Lipase
inhibitor
Lipase
activator
FFA
ATP
Lysosome
Mitochondria
(a) (b)
Figure 1: Lipolysis of lipid droplets. (a) Schematic representation of the main lipid and protein components of lipid droplets (LDs) and
mechanisms of lipid mobilization (lipolysis) by cytosolic lipases. (b) Lipolysis by lipophagy. Schematic representation of the formation of
autophagic vacuoles at the surface of an LD. PLIN: perilipin; Atg: autophagy-related protein; FFA: free fatty acids.
of phospholipids and separated from the hydrophilic cytoso-
lic environment by a coat of structural proteins, known
generically as perilipins (Figure 1)[ 8, 9]. Despite their
misleading appearance of inert stores, studies during recent
years have revealed that LD are sites of high activity and that
their functions are not limited to passive store of lipids. In
fact, their dynamic nature, multifunctionality, and deﬁned
identity have now conferred upon them the category of
intracellular organelles [8, 9]. Furthermore, as many other
organelles, LDs have been shown to interact in a regulated
manner with other intracellular compartments (likely, to
provide them with speciﬁc lipids for their membranes) and
to adapt to changes in the cellular environment [10, 11].
A growing theme in the ﬁeld of LD research is now the
identiﬁcation of functions for the LD beyond those related to
lipid metabolism or supply of membrane lipids. Pioneering
among those has been the ﬁnding that the hydrophobic
matrix of the LD can become a sequestering surface for mis-
folded proteins that if left free in the cytosol could organize
intooligomericandaggregatedproductshighlytoxicforcells
[12, 13]. LD sequestration of proteins does not only apply to
pathogenic proteins destined for degradation, but also may
have a regulatory role in the availability of some fully func-
tional proteins. For example, certain histones elude nuclear
translocation through dynamic and reversible interactions
with LD [14]. Interestingly, pathogens such as some types of
viruses, have found in the LD ideal platforms for assembly
[15, 16].
2.2. Mobilization of Intracellular Lipids through Lipolysis:
Novel Role of Autophagy. Although lipid droplets are partic-
ularly prominent in the adipose tissue—where they organize
as a single large droplet (up to 100μm diameter) that
occupies almost the totality of the cytoplasm—all cells
contain lipid droplets to variable extents that range from 0.1
to 10μm. In addition to size diﬀerences, the adipose tissue
LD has a core predominantly formed by triglycerides (TGs)
whereas in most cells cholesterol and TG share the nuclear
core of the LD [8, 9].
LD originate from the ER and maintain a close connec-
tion with this organelle, which facilitates exchange of lipids
and proteins between both compartments to accommodate
to the metabolic requirements of the cell [10]. Mobilization
of the lipids inside the LD occurs through lipolysis. The
interaction of lipases present at the surface of the LD with
the structural proteins that surround LD and with inhibitory
proteins in the cytosol contributes to modulate the rate of
lipolysis[17].Cellsactivatelipolysisnotonlywhentheyneed
energy but also in response to a large aﬄuence of lipids to
prevent stores from becoming compromisingly enlarged for
the cell.
Although, traditionally, mobilization of LD by lipolysis
hasbeensolelyattributedtotheLD-associatedlipases,recent
studies have revealed a role for autophagy in LD breakdown
(Figure 1). The presence of lipases in the lysosomal lumen,
along with a large variety of hydrolases such as proteases,
glycasesandnucleases,hasbeenacknowledgedsincetheearlyInternational Journal of Cell Biology 3
days of the discovery of this organelle. However, lysosomal
lipases, also known as “acid lipases” because of their optimal
acidic pKa, were thought to serve mainly in the degradation
oflipidscontributedbythedietthroughendocytosisorthose
present in the membranes of the organelles digested during
the autophagic process. The elevation of LD to the category
of cytosolic organelles was in part a motivation to address
theirturnoverbyautophagy.Thiscatabolicprocessiscapable
of sequestering whole cytosolic organelles inside double-
membrane vesicles known as autophagosomes, which deliver
this cargo to lysosomes upon heterotypic fusion with their
membrane [18, 19]. Each of the events of the autophagic
process is coordinated by a complex network of more than
32genesandtheirproteinproducts(autophagy-relatedgenes
(ATGs) and proteins (Atgs)). Atgs participate at the level of:
(1) activation, (2) nucleation of the autophagosome mem-
brane that forms de novo through conjugation of proteins
and lipids from diﬀerent cellular compartments, (3) elonga-
tion of the membrane and sealing to form the autophago-
some, (4) traﬃcking toward the lysosomes, and (5) fusion of
the two membranes [18].
The ﬁrst hint that LD could become substrates of the
autophagic process originated from studies in cultured hepa-
tocytes knocked down for Atg5, one of the genes essential for
theformationofautophagosomes[20].Hepatocytesrespond
to an acute oleic challenge by increasing lipolysis, which
would prevent massive enlargement of the LD compartment.
Oleic challenge resulted in a marked increase in the number
and size of LD in cells with compromised macroautophagy.
T h es a m ew a st r u ein vivo, when knockout in liver of
anotheressentialautophagygene(Atg7)ledtoanaccelerated
development of liver steatosis (fatty liver) in the autophagy
compromised animals, when compared to control animals
[20]. Detailed biochemical and functional analyses helped
in establishing that the observed lipid accumulation did
not result from increased formation of LD or reduced lipid
secretion from hepatocytes, but that, instead, it could be
explained almost exclusively on the basis of reduced lipolysis
[20].
It is possible that, through mechanisms yet to be identi-
ﬁed, changes in autophagic activity may modulate the LD-
associated lipases and contribute to the observed changes in
lipolysis. However, independent of this possibility, there is
nowevidencethattheautophagicsystemcontributesdirectly
to the mobilization of lipids from LD to lysosomes, wherein
luminal lipases mediate their lipolysis. In fact, neutralization
of the lysosomal pH, that would have a marked eﬀect on the
lysosome-resident lipases but does not modify the activity of
the cytosolic lipases, was enough to almost completely block
the lipolysis activated in response to a lipid challenge [20].
2.3. Recognition of LD by the Autophagic System. Sequestra-
tion of cytosolic components inside the forming autophago-
some was considered for a long time a nonselective in-
bulk process by which cytosolic material was randomly
delivered for lysosomal degradation. However, recent years
have revealed the existence of a growing number of pro-
teins dedicated to the tagging and recognition of cytosolic
components for autophagic degradation [21]. In the case of
intracellular protein aggregates, the presence of polyubiqui-
tinated chains formed through speciﬁc types of linkage (the
best characterized uses the lysine 63 in ubiquitin to link one
ubiquitin moiety to another in the polyubiquitin chains)
is the tag identiﬁed by the cargo-recognition machinery
[22]. Similarly, ubiquitination of proteins on the surface
of peroxisomes and of diﬀerent pathogens contribute to
their segregation towards the autophagic system [23, 24].
However, ubiquitin is not the only signal identiﬁed as
marker for autophagic degradation. Selection of mitochon-
dria for mitophagy (selective degradation of mitochondria
by autophagy) has been shown to occur through diﬀerent
mechanisms,whichlikelycoexistinmostcells.Inmostcases,
changes in structural components of the mitochondrial
membrane are identiﬁed by partner cytosolic proteins (such
as Parkin or Nix), that once bound at the surface of this
organelle, tag it for degradation [25]. All cargo recognition
molecules or autophagy receptors share their ability to bind
to the tagging molecule in the organelle to be degraded as
well as to speciﬁc components of the autophagic machinery
(in almost all cases the light chain protein 3 or LC3) [21,
26]. This recruitment of autophagic components toward the
cytosolic material to be degraded is proposed to initiate the
in situ formation of the autophagosome around this material
and to mediate selectivity.
Some levels of lipophagy may always occur even during
the random sequestration of cytosolic material by “in-
bulk” autophagy. In fact, analysis of the components inside
autophagosomes in cells maintained in basal conditions
revealed the presence of lipid material and LD structural
proteins inside these vesicles, along with other cytosolic
material [20]. However, as described in the previous section,
when lipophagy is activated in response to a lipid challenge
or prolonged starvation, there seems to be a switch toward
the preferential sequestration of LD, supporting some level
of selectivity in this process [20]. An intriguing observation
inthestudiesofhepaticlipophagywasthefactthatLDdonot
alwaysseemtobesequesteredasa“whole”bytheautophago-
somes,but,onthecontrary,inmanyinstances,onlyfractions
of the LD underwent autophagy (Figure 1)[ 20]. Thus,
membranous structures enriched in LC3, in support of their
autophagic origin, appear to grow from the surface of the
droplettowardstheinnercore.Oftenthesemembranescurve
to ﬁnally seal, giving rise to double-membrane vesicles of a
slightlysmallersizethanaconventionalautophagosome(50–
100nm) and contain only components of the LD in their
lumen. Interestingly, formation of the membranes seems
to be polarized in only one site on the surface of the LD.
Other components of the autophagic machinery, such as
Atg5andAtg7,alsolocalizetotheseareasoftheLDinfurther
support that formation of the limiting membrane occurs at
the surface of the LD (Figure 1)[ 20].
In the process of de novo formation of the autophagic
membrane, Atg7 acts as the enzyme regulating conjugation
o fA t g 1 2t oA t g 5( t os e r v ea ss c a ﬀold for assembling other
components of the forming membrane), as well as the
conjugation of LC3 to a lipid (phosphatidylethanolamine,
PE) to generate LC3-II that is one of the best character-
ized structural components of the autophagosomes [18].4 International Journal of Cell Biology
Interestingly, Atg7 is not required for the recruitment of LC3
to the LD, since this protein, although in its nonconjugated
form, is still found associated to LD in cells defective in Atg7
[20]. PE, the only lipid known to conjugate to LC3, is among
the phospholipids that contribute to form the delimiting
phospholipidmonolayerofLD[27].Thespeciﬁcmechanism
bywhichthelimitingautophagosomemembranegrowsfrom
the LD surface is still poorly characterized, but the presence
of membrane-like structures in the LD core has been
previously described [28]. In addition, although the core is
predominantlycomposedoflipids,someproteinscanalsobe
detectedinthisregion.Earlystudieshavesuggestedthatthese
proteins may form complexes with phospholipids to form
structures compatible with the hydrophobic environment
inside the LD [29]. In this respect, conjugation of LC3 to PE
on the surface of the LD may provide the right conformation
for the forming membrane to advance towards the inside of
the LD.
Thedeterminantsforautophagicinitiationonthesurface
of a LD remain unknown. Polyubiquitination has been
detected in polarized areas of LD in part resulting from the
accumulation of clusters of polyubiquitinated apolipopro-
tein B (ApoB) on their surface [13] .T h ef a t eo fA p o Bi n
this location seems to be to undergo lysosomal degradation.
Whether or not the lysosomal degradation of ApoB occurs
as a result of the activation of lipophagy and how the
accumulation of this protein contributes to the initiation
o ft h ep r o c e s sr e q u i r e sf u t u r ei n v e s t i g a t i o n .R e c e n ts t u d i e s
have shown now the integration into the LD surface of
the ancient ubiquitous protein 1 (AUP1), which bears a c-
terminus able to bind enzymes involved in ubiquitination
[30].WhetherornotthepresenceofAUP1inLDisnecessary
or precedes the arrival of the autophagic machinery requires
future investigation.
Of particular interest is the fact that LDs have been
shown to dynamically interact with two of the organelles
that have been proposed as sites of formation of the lim-
iting membrane of the autophagosomes—the ER and the
mitochondria (Figure 1)[ 11, 31]. Interactions with the
ER may be related to LD biogenesis, as this is the com-
partment from where these organelles originate, but may
also favor the distribution of lipids from the LD towards
other organelles through the endosecretory pathway. In the
case of mitochondria, the close interaction between LD
and the outer-membrane of this organelle could facilitate
delivery of the FFA released by lipolysis for mitochondrial
β-oxidation. However, considering the described association
of the autophagic initiation complex to punctual areas in the
membrane of the ER and the mitochondria, and the forma-
tion of cup-like precursors of the limiting membrane of the
autophagosomes from these regions [32, 33], it is tantalizing
to at least propose that the previously described interactions
of LD with these organelles, could also contribute to the
initiation of their autophagic degradation.
3. Physiology of Lipophagy
3.1. Liver Lipophagy. As described in previous sections,
mobilization of LD by autophagy was ﬁrst observed both
in cultured hepatocytes in response to fatty acid exposure,
and in liver of mice maintained on a diet enriched in fat
for prolonged periods of time (4 months) [20]. The liver
responds to the massive inﬂux of lipids from the blood by
upregulating LD biogenesis, as a mechanism of defense
against the toxicity of FA, which upon esteriﬁcation get
converted into TG and stored into LD [17]. However, in
order to prevent uncontrolled expansion of LD, activation of
lipolysis also occurs under these conditions and contributes
to maintain LD size. Failure to regulate lipid accumulation in
hepatocytes may be the basis of pathogenic conditions such
as liver steatosis and steatohepatitis [8]. Autophagy has now
been added to the mechanisms that control the growth of the
hepatic LD under these conditions (Figure 2).
Besides lipid challenges, other stimuli such as starvation
also engage the lipolytic contribution of the autophagic sys-
tem. Classic measurement of protein catabolism in liver dur-
ing starvation, revealed that most of the protein degradation
in this organ occurs during the 4–6h that follow starvation,
and that protein breakdown, even of autophagic origin,
decreases markedly once the 8–10h of starvation are reached
[4]. However, this decrease in autophagic degradation of
proteins by autophagy is not equivalent to a decrease in
overall autophagic activity. Formation and clearance of au-
tophagosomes seems to be maintained throughout the
starvation period, but there is a consistent change in the
type of cytosolic components sequestered in these vesicles
[20]. Whereas cytosolic proteins and some organelles are
the main cargo of the autophagic process during the early
hours of starvation, as lack of nutrients persists, there is a
gradual change towards preferential sequestration of lipid
droplets inside autophagosomes (Figure 2)[ 20]. This selec-
tive autophagy of lipid stores, known now as lipophagy,
accounts for a high percentage of the lipolysis occurring
during prolonged starvation in liver.
Interestingly, although lipophagy is markedly upregu-
lated in response to lipid challenges and during prolonged
starvation, it is possible that a certain percentage of degrada-
tion of lipid stores in lysosomes occurs continuously in many
cell types. Thus, blockage of autophagy through knockdown
of any of the essential Atg in hepatocytes in culture, leads
to a signiﬁcant increase in the number of lipid droplets in
these cells even when maintained under normal nutritional
conditions and in the absence of any additional challenge
[20]. Similar basal lipophagy has also been observed in cell
types not typically known to store fat such as ﬁbroblasts,
macrophages, T cells, dendritic cells, lymphoblasts, glia,
striatal cell lines, and even primary neurons [20, 34–36],
although the relative contribution of autophagy to basal
lipolysis may vary depending on the cell type. Further
studies are necessary to determine the reasons behind the
coexistence of the two diﬀerent mechanisms for lipolysis—
the one mediated by the cytosolic lipases and the one
occurring through the autophagic system. It is possible that
activationofoneortheothermaymainlyleadtoquantitative
diﬀerences (i.e., lipophagy may be able to provide large
amounts of FFA in shorter time). However, because the
lysosomal lipases have been poorly characterized, it is also
possible that the quality and type of the resulting lipolyticInternational Journal of Cell Biology 5
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Figure 2: Autophagy and lipid metabolism in liver. (a) Basal lipophagy: some level of mobilization of LD by autophagy occurs continuously
in all tissues including the liver. (b) Inducible lipophagy: stimuli such as prolonged starvation or maintained lipid challenges induce
liver lipophagy to regulate LD growth. Failure to upregulate autophagy under these conditions could results in liver steatosis. (c)
Lipogenesis/lipolysis balance: autophagy may also contribute to LD formation by mechanisms still unknown. A partial blockage of the
autophagic process may modify the lipogenic-lipolytic balance in one direction or another depending on the cellular conditions.
products diﬀers between cytosolic and lysosomal lipases.
Lastly, in light of the growing evidence in support of the
heterogeneity of the cellular LD, it is also plausible that the
two lipolytic systems target diﬀerent subpopulations of LD.
3.2. Specialized Lipophagy in the Hypothalamus. As detailed
earlier, lipophagy appears to contribute signiﬁcantly to the
mobilization of cellular lipids for provision of energy [2].
However, the identiﬁcation of lipophagy in cell types other
than those involved in lipid storage, such as in immune or
neuronal cells, suggests that autophagic turnover of lipids is
perhapsagenericmechanismfortheutilizationofcellularfat
stores in diverse cell types. In fact, recent reports have now
included two additional cell types; hypothalamic neurons
[35]a n dm a c r o p h a g ef o a mc e l l s[ 37], to the increasing list
of cells where lipophagy has been shown to be present and
functionally important.
The neurons within the mediobasal hypothalamus
(MBH) form part of a focal neural network that integrates
nutritional and hormonal information from two main cel-
lular kinases, the mammalian target of rapamycin (mTOR)
[38] and the phosphoinositol-3-kinase (PI3K) [39]t oc o n -
trol food intake and energy balance [40]. Hypothalamic fatty
acid metabolism, amongst other neuronal mechanisms, has
been linked to the regulation of appetite [41, 42]. Although
recent work suggests that neuronal FFA availability and oxi-
dation provide the energetic requirements for activation and
ﬁring of orexigenic agouti-related peptide (AgRP) neurons
[41],thelipolyticmechanismsthatgenerateneuron-intrinsic
FFA have remained poorly elucidated. Since autophagy is
activated by starvation in most cells [43], it was plausible
that autophagic mobilization of lipids in the hypothalamus
could contribute to the generation of neuronal FFA during
starvation that, in turn, trigger mechanisms driving food
intake. In fact, a recent study in mice knockout for Atg7 in
AgRP neurons shows that the hypothalamus, indeed, needs
autophagy to upregulate expression of AgRP in response
to nutritional depletion [35]. This indicates the distinctive
characteristic of hypothalamic neurons in their ability to
activate autophagy, quite unlike other regions of the brain
in which autophagy does not seem to be under this type
of nutritional regulation [1]. The activation of autophagy
occurred in parallel to starvation-induced increases in hy-
pothalamic FFA uptake (Figure 3), suggesting that, as in
the case of the liver [20], acute FFA stimulus might be a
mechanismforactivationofhypothalamicautophagyduring
starvation.Indeed,theexposureofhypothalamiccellstoFFA
orFFA-richserumfromstarvedrodentsincreasedautophagy
(Figure 3)[ 35].
The activation of autophagy in hypothalamic neurons
upon acute lipid stimulus associated with increases in the
levels of phosphorylated AMPK and ULK1 [35], a kinase
involved in the regulation of the autophagic process and
recently described to be an AMPK substrate [44]. These
ﬁndings indicate that hypothalamic AMPK and ULK1 may
contribute to a FFA sensing mechanism that modulates6 International Journal of Cell Biology
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Figure 3: Conceptual model for hypothalamic lipophagy in control of food intake. In the fed state, active PI3K/mTOR signaling main-
tains autophagy at basal lower levels. Starvation increases circulating free fatty acids (FFAs), which activate hypothalamic autophagy by
mechanisms that may in part require activation of AMPK/ULK1. These FFAs taken up by hypothalamic neurons are rapidly esteriﬁed into
neutrallipidswithinlipiddroplets.Activationofhypothalamicautophagymobilizesneuronallipidsforthecontrolledavailabilityofneuron-
intrinsicFFAsthatincreaseAgRPexpressionandfoodintake.AgRP:Agouti-relatedpeptide,AMPK:AMP-activatedproteinkinase,FFA:free
fatty acids, LD: lipid droplets, PI3K: phosphoinositide 3-kinase, mTOR: mammalian target of rapamycin, and ULK1: unc-51-like kinase 1.
autophagy in response to changes in nutrient signals. How-
ever, the mechanisms connecting FFA release and AgRP
expression remain unknown for the most part. Although it
is possible that FFA modulate some of the signaling cascades
involved in AgRP regulation [45], a direct eﬀect of the au-
tophagic process on secretion of AgRP-containing vesicles
cannot be ruled out.
The immediate fate of the FFA taken up by hypothalamic
cells is esteriﬁcation into neuronal LD, which underscored
the requirement of a lipolytic mechanism to liberate neu-
ronal FFA during starvation. Indeed, the activation of
hypothalamic autophagy observed under these conditions,
leads to increased mobilization of neuronal lipids to lyso-
somes [35]. The physiological consequence of these inter-
actions is the generation of neuronal FFA, since inhibiting
lysosomal hydrolysis or interfering with the autophagic
process signiﬁcantly decreases hypothalamic FFA levels.
Lipophagy-generated hypothalamic FFA directly regulate
the increase in orexigenic AgRP expression that occurs in
AgRP hypothalamic neurons in response to starvation or
to exposure to extracellular FFA [35]. In fact, selective
blockage of autophagy in AgRP neurons has been shown
to reduce fasting-induced increases in hypothalamic AgRP
levels, food intake, and body weights. Interestingly, mice
deﬁcient in autophagy in AgRP neurons also displayed
higher levels of the anorexigenic peptide α-melanocyte
stimulating hormone (MSH), which is produced within the
adjacent proopiomelanocortin (POMC) neuronal popula-
tion,whichcouldcontributetothereducedadiposityinthese
mice.
In this respect, it is interesting to note that the eﬀect of
autophagy in lipid mobilization and the downstream con-
sequences of neuronal lipophagy may be very neuronal
type-speciﬁc. For example, a recent study using acute in-
trahypothalamic injection of siRNA against Atg7 revealed
increased adiposity and glucose intolerance in the injected
mice [46], in contrast to the lean phenotype observed when
only AgRP autophagy is compromised. It is possible that
adiposity in this model occurred from concurrent reduction
of atg7 in both AgRP and POMC neuronal populations,
or from autophagic deﬁciency in additional cell types, for
instance hypothalamic glial cells, also shown to regulate
glucose homeostasis [47]. However, as the actual impact of
the siRNA injection in the autophagic ﬂux in this model
is not known, is not possible to discard that diﬀerences in
eﬃciency of the autophagic compromise between POMC
and AgRP neurons are the real reason behind the diﬀerent
phenotype, or even that autophagy was not aﬀected in the
AgRPneuronsandthephenotypeonlyresultedfromreduced
POMC autophagy.
Although future investigation is required to clarify the
cell type diﬀerences and to identify additional stimuli that
may also modulate hypothalamic autophagy, the current
ﬁndings highlight an exciting new role for lipophagy in
control of food intake and whole body energy balance by
modulating the “controlled production” of neuronal FFA
that regulate AgRP levels [35] (Figure 3). In this way, the
contribution of autophagy to the cellular and organismal
energetic balance is no longer merely limited to its role in
active breakdown of macromolecules or cellular stores to
obtain energetic products, but has been raised to a more
global regulatory function that includes the modulation of
food intake. Forthcoming studies should help in addressing
the possible implications of these ﬁndings for metabolic
diseases such as obesity and the impact that these metabolic
changes could have on hypothalamic autophagy.International Journal of Cell Biology 7
3.3. Autophagy in the Adipose Tissue. The presence of li-
pophagy in diverse cell types raises the question whether
lipophagy might also serve to mobilize lipids within the
principal fat storing organ in the body, the adipose tissue.
Surprisingly,recentreportsbytwoindependentgroupsdem-
onstrate a completely new and unexpected function of
autophagy in regulating adipose physiology [48, 49], which
is quite distinct from the role of autophagy in mobilizing
lipids observed in other cell types [20, 34–36]. In fact,
adipose-selective knockout of essential autophagy genes in
mouse signiﬁcantly reduced adipocyte lipid droplet content
and fat tissue mass [48, 49]. Likewise, blocking autophagy
in cultured preadipocytes decreased cellular triglyceride
content and levels of key adipogenic transcription factors
CEBP-α (CCAAT/enhancer-binding protein alpha), CEBP-β
(CCAAT/enhancer-binding protein beta) and PPAR-γ [48].
Conceivably, reduced expression of adipocyte-speciﬁc genes
led to the formation of an adipose tissue that predominantly
consisted of immature fat-deﬁcient preadipocytes judging by
their reduced levels of terminal diﬀerentiation markers (fatty
acid synthase, fatty acid-binding protein-4 (FABP-4/aP-2),
glucose transporter 4 (GLUT4), or stearoyl CoA desaturase
1) [48].
Intriguingly, selective inhibition of autophagy in white
adipose tissue (WAT) in vivo not only impaired WAT
diﬀerentiation but also introduced brown adipose tissue-
(BAT-) like features in autophagy-deﬁcient WAT [48]. The
autophagy-deﬁcient white adipocytes exhibited a cellular
morphologythatresembledcloselythatofbrownadipocytes.
For instance, atg7-deﬁcient white adipocytes displayed
increased number of smaller multiloculated lipid droplets
and mitochondria, rounded nuclei, and larger cytoplasmic
size [48, 49]. The molecular characteristics of the adipose
tissue in the autophagy-deﬁcient mice also mimicked those
of BAT as reﬂected by increased levels of brown adipogenic
factors, PPAR-γ transcriptional coactivator (PGC-1 α), and
uncoupling protein-1 (UCP-1) [48]. Acquisition of BAT-like
properties resulted in higher adipose tissue β-oxidation rates
in knock-out animals than in controls [48, 49].
The physiological consequences of this shift in WAT
phenotypewereadecreaseinbody weight,reducedadiposity
and resistance against high fat diet-induced alterations in
glucose homeostasis [48, 49]. Although, the mechanism
by which autophagy controls adipocyte diﬀerentiation or
modulates the phenotypic switch from WAT to BAT-like
is unclear, a likely possibility is that autophagy modulates
levelsofkeyregulatoryproteinstocontroladipocytecellfate,
diﬀerentiation and fat storage. However, it is still plausible
that speciﬁc autophagy-related components may be directly
involved in the process of adipogenesis and that this function
is not only limited to the adipose tissue. This concept is
supported by studies performed at ages before adulthood
in the same mouse model null for autophagy in liver used
in the discovery of hepatic lipophagy [50]. In contrast to
the massive accumulation of lipids observed in the adult
animals, very young animals, at least when unchallenged,
had consistently lower hepatocyte content of LD [50]. The
previously described association of LC3-II to LD [20], also
conﬁrmed in this latter work, was proposed to be required
for LD formation. Since expression of the enzyme used to
ﬂox out the autophagic gene does not start in this mouse
model until 3-4 months after birth, it is possible that if
autophagy is involved in both formation and mobilization of
LD, the partial blockage of autophagy was initially suﬃcient
to cope with the lipophagic requirements of the young
animals and prevent the accumulation of LD. However, as
the animals reached adulthood, the complete and persistent
blockage of the autophagic system tilted the balance between
lipogenesis and lipolysis toward the former one, leading to
LD accumulation.
This dual involvement of autophagy in lipogenesis (LD
formation) and lipolysis proposed in the liver now raises the
question of whether a similar dual role could also occur in
the adipose tissue. In fact, recent studies with a mouse model
deﬁcient in caveolin 1 have shown lipoatrophy of the adipose
tissue mediated by massive upregulation of autophagy in
this tissue [51]. Future studies with inducible autophagy
knockouts in the adipose tissue of adult mice are needed to
determine if autophagy does contribute to lipid mobilization
also from fully formed adipose tissue.
4.Pathology of Lipophagy
4.1. Dual-Eﬀect of Lipids on Autophagy. After the ﬁrst ob-
servations demonstrating the existence of lipophagy and the
upregulation of this process in response to a lipid challenge
[20],numerousstudieshaveconﬁrmedthestimulatoryeﬀect
of dietary lipids on the autophagic process. Upregulation of
autophagy in response to increased FFA has been demon-
strated in neurons, muscle, pancreas, mammary epithelial
cells, liver-derived cells, and even in colon cancer cells [52–
56]. Although the mechanisms that modulate the activation
of the autophagic process under these conditions are still
poorly elucidated, at least in the case of the pancreatic
beta cell, autophagic activation has been proposed to occur
through activation of the c-Jun N-terminal kinase 1 pathway
in a manner independent of ER or oxidative stress [53].
In contrast to this stimulatory eﬀect of a lipid challenge
on the autophagic system, an equal number of studies
have started to report inhibition of autophagy in response
to exposure to high concentrations or particular type of
lipids (Figure 4). For example unsaturated FFA such as
o l e i ca c i dh a sam a r k e ds t i m u l a t o r ye ﬀect on autophagy in
many cells, at least up to some concentrations [20, 57, 58].
In contrast, saturated FFA such as palmitic acid—maybe
due in part to its lower incorporation into LD—remains
in the cytosol at higher concentrations and suppresses
autophagy [58]. Likewise, in animals exposed to a high-fat
diet for prolonged periods of time it is possible to detect
an increase in autophagic activity during the ﬁrst weeks
of treatment, which is progressively followed by a gradual
decrease in autophagy. This decrease further contributes to
the expansion of the LD compartment, eventually leading
to hepatotoxicity and steatosis [20, 57, 58]. Interestingly,
the switch from activation to inhibition of autophagy in
response to lipogenic stimuli can also be cell type depen-
dent. Thus, same amounts of oxidized low-density lipopro-
tein that stimulate autophagic activity in schwannoma8 International Journal of Cell Biology
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Figure 4: Lipophagy in pathology and aging. Alterations in the autophagic system and in its ability to mobilize intracellular lipids may
underline the basis of important human disorders. The possible links of lipophagic malfunctioning with obesity, atherosclerosis, and the
metabolic syndrome of aging are depicted.
cells have been shown to be toxic for neuroblastoma cells
[54].
Although many mechanisms could contribute to the
inhibitory eﬀe c to fF F Ao na u t o p h a g y ,as y s t e m a t i ca n a l y s i s
of the diﬀerent steps of the autophagic process has revealed
a primary defect in the fusion between autophagosomes
and lysosomes in cells exposed to high concentrations of
FFA or in animals subjected to prolonged high-fat diet [57].
Interestingly, this failure to deliver autophagosome cargo
directly to lysosomes is initially compensated for by increas-
ing fusion of autophagic compartments with late endosomes
(togeneratewhatisknownasanamphisome)[57].However,
as the high levels of intracellular lipids persist, defective
intracellular turnover becomes evident, either because of
further compromise of the pathway or maybe because of an
additionalfailureintheendocyticsystemasautophagiccargo
builds up in these compartments. Analysis of autophagic
vacuoles from animals exposed to a high-fat diet revealed
that changes in the lipid composition of the membrane of
these vesicles are behind their compromised fusogenicity
[57].
This-dual eﬀect of dietary lipids on autophagy and
lipophagy should be taken into consideration when contem-
plating manipulations of the autophagic system as a thera-
peutic strategy for metabolic disorders.
4.2. Liver Lipophagy and Hepatic Diseases. The fast develop-
ment of steatosis and fatty liver observed in mice defective
for autophagy in this organ [20] strongly supported the
contribution of altered autophagy to the pathogenesis of
this common disease. In fact, a compromise in hepatic
autophagy has been proposed to underline also the basis
for the accumulation of LD upon exposure to toxic con-
centrations of ethanol [59]. Furthermore, recent studies
have demonstrated that pharmacological upregulation of
autophagyreduceshepatotoxicityandsteatosisinanalcohol-
induced model of fatty liver [59]. However, future studies
are needed before autophagy activation can be used as
a generalized treatment against this disease, because, for
example, upregulation of the autophagic process in hepatic
stellate cells has been shown to favor their activation and
consequently initiate liver ﬁbrosis [60]. The liver responds
to some stressors through global activation of autophagy,
including degradation of lipids, proteins, and organelles.
However, in other instances upregulation of autophagy as
a protective mechanism against liver injury can be speciﬁc
for lipophagy. For example, the autophagy upregulated as a
ﬁrst line of defense against alcohol-induced toxicity in liver,
selectively targets mitochondria, and lipid droplets, while
excluding soluble cytosolic proteins and other organelles
[59]. Future eﬀorts should focus in understanding how
selective forms of autophagy can be individually modulated
for therapeutic purposes.
The recently discovered capability of the autophagic
system to mobilize hepatic lipids is also utilized by viruses
to favor their replication. Earlier studies have shown that
although autophagy is usually an eﬃcient mechanism in
the defense against most viral infections, upregulation of
autophagy could also favor replication of some viruses such
as the dengue virus. Recent studies have demonstrated that
dengue virus-dependent induction of autophagy mediates
LD breakdown and release of FFA necessary to maintain the
high levels of intracellular ATP required for dengue viral
replication [61]. Future studies are needed to determineInternational Journal of Cell Biology 9
which subset of hepatotropic virus makes use of lipophagy
for their own replication and whether blockage of the
autophagic system can be performed in this organ in a
selective way to preferentially aﬀect virogenesis but not
normal liver metabolism.
4.3. Metabolic Disorders. The ﬁnding that autophagy is re-
quired for adipogenesis has elicited a considerable interest
in the interplay between autophagy and metabolic disorders
such as obesity.
Studiesperformedinhumansubjectswithdiﬀerenttypes
and degrees of obesity have revealed a direct correlation
between autophagic activity and the sizes of various fat
depots. Interestingly, autophagy was found to be inappro-
priately active in omental fat tissues extracted from obese
individuals, and, in fact, autophagic activity was remarkably
raised in insulin-resistant obese subjects [62]. This indicates
that although functional autophagy may be a requirement
for adipose diﬀerentiation during development, autophagy
might also be involved in the maintenance of adipose tissue
size and lipid storage in adults. The fact that autophagic
upregulation occurs before obesity-associated morbidity
becomes manifested, still leaves open the possibility that this
system could be activated as a defensive mechanism against
the increase in intracellular lipids. However, the ﬁnal out-
come and autophagy eﬀect may be very diﬀerent depending
on the metabolic status. For example, in adipocytes from
type 2 diabetes patients characterized by unresponsiveness to
insulin, maintained attenuation of mTOR has been recently
described and proposed as the main mechanism responsible
for the upregulation of autophagy in these cells. The con-
comitant increase in LD formation under these conditions
along with their enhanced autophagy favors cellular toxicity
due to the excessive release of FFA from LD. It is anticipated
that blockage of autophagy, or at least downregulation to a
normal level, may be better under these conditions [63].
Lipophagy has been recently proposed as a possible
defensive mechanism against atherosclerosis, or the thick-
ening of the artery walls due to abnormal accumulation of
lipid deposits in macrophage foam cells [37]. The recent
ﬁnding that autophagy contributes to lipolytic mobilization
of LD in macrophages also, provides now a new possible
mechanism for the pathogenesis of atherosclerosis. This
study has revealed that macrophage lipophagy is upregulated
both in vitro and in vivo in response to lipid loading and
that failure to upregulate the autophagic system, in mice
defective for this pathway, results in ineﬃcient clearance of
cholesterol in macrophages [37]. In light of the inhibitory
eﬀectthathighconcentrationsofintracellularlipidscanhave
on autophagy [57], it is reasonable to propose that chronic
exposure to high levels of circulating lipids may compromise
the autophagic system of the artery wall macrophages and
lead to their transformation into “foam cells” as lipids
accumulate in their cytoplasm. This massive accumulation
of lipids is the seeding for the subsequent formation of
the atherosclerotic plaque. Current therapeutic strategies
in this disease are aimed at promoting cholesterol eﬄux
from these macrophages to reduce the size of the lipid-
enriched plaque that they form beneath the endothelial
cells. Consequently, manipulations aimed at enhancing ma-
crophage autophagy and thus favoring cholesterol eﬄux
from these cells, may have therapeutic potential in the ath-
erosclerotic artery walls. Interestingly, the contribution of
changes in autophagy to atherosclerotic plaque development
may go beyond macrophages and involve also the smooth
muscle cells of the arterial wall. Recent studies have shown
compromised autophagy in these cells as a consequence of
the inﬂammatory response associated to the plaques [64].
4.4. Aging. Autophagic activity decreases with age in most
tissues and organisms [65]. The fact that a decline in
autophagic activity, and in particular in lipophagy, would
contribute to intracellular accumulation of LD and that, as
described in previous sections, these abnormally expanded
lipid stores would further reduce autophagic activity, makes
this an attractive feedback loop for the perpetuation of the
metabolic syndrome of aging (characterized by hypercholes-
terolemia, accumulation of lipid deposits in organs, and
insulin resistance) (Figure 4). Interestingly, and in some way
contra intuitively, treatment with antilipolytic agents has
been shown to improve the age-related hypercholesterolemic
phenotype and overall health-span in old mouse models
[66]. However, recent studies support that most of the
beneﬁcial eﬀect observed with these agents is dependent on
their ability to induce autophagy, likely as a response to the
increase in intracellular lipid stores [67].
Genetic connections among autophagy, lipid atheroscle-
rotic, and longevity have also been recently highlighted in
studies in C. elegans [68]. Functional autophagy is necessary
in this model to maintain the activation of a cellular lipase
(LIPL-4) and conversely, this lipase is required for induction
ofautophagy.Interestingly,boththeactivityofthislipaseand
autophagy are required to attain the extension in life span
observed upon germline removal in worms. Although the
speciﬁc lipid targets of this lipase and the way in which it
participates in autophagy remain unknown, it is tempting to
propose that part of the eﬀect in life-span could be due to
better intracellular lipid handling by lipophagy.
5. Concluding Remarks
The recent discovery of lipophagy has contributed to link
two major intracellular catabolic pathways autophagy and
lipolysis.Thisnewfunctionofautophagyinlipidmetabolism
expands the physiological relevance of the autophagic pro-
cessbymakingitscontributiontotheenergeticbalancemore
relevant (when considering the higher energetic value of
lipids versus proteins), but also including now under the list
ofautophagicfunctionsthecontrolofmanyoftheregulatory
activities that lipids exert inside cells.
There are however a large number of standing questions
that deserve immediate attention. Does lipophagy regulation
occur through similar signaling pathways to those described
for other types of autophagy? How are LDs selectively target-
ed by the autophagic machinery? Is there preferential degra-
dation of a subset of LD by lipophagy? Are there differences
betweenthetypesoflipidbyproductsgeneratedbylipophagy
when compared to cytosolic lipolysis? What determines the10 International Journal of Cell Biology
threshold for the switch from a stimulatory to an inhibitory
eﬀect of FFA on lipophagy? And also, in a more general
context, is upregulation of autophagy protective against all
types of lipotoxicity in vivo? What are the possible eﬀects
of lipophagy on the combinations of metabolic defects that
often coexist in our population such as obesity, diabetes,
and hyperlipidemia? Does defective hypothalamic lipophagy
with age contribute to the reduced food intake observed in
advanced aging [69]?
Although these are still early days for lipophagy, there
is now ample evidence that organ-speciﬁc targeting of this
process may have implications for development of novel
therapeuticinterventionsagainstcommonhumanmetabolic
disorders such as obesity and insulin resistance.
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